Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model

Shi-jing Huang; Xian-hui Zhang; Yan-yun Wang; Ju-hua Pan; Han-ming Cui; Su-ping Fang; Wei Wu; Jun Zheng; Duo-jiao Li; Ge Bai

doi:10.1007/s11655-014-1343-0

Your Location：

Home >

Browse articles >

Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model

OriginalPaper | Updated：2021-08-27

- Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model
- Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model
- 中国结合医学杂志（英文版） 2014年20卷第4期页码：280-285
- Affiliations：
  
  Traditional Chinese Medicine Research and Development Center, Guang’anmen Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 30672696 and 81072801)
- DOI：10.1007/s11655-014-1343-0
  中图分类号：
- 纸质出版日期：2014，
  
  网络出版日期：2014-2-24，
Scan for full text
Huang, Sj., Zhang, Xh., Wang, Yy. et al. Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model., Chin. J. Integr. Med. 20, 280–285 (2014). https://doi.org/10.1007/s11655-014-1343-0

Shi-jing Huang, Xian-hui Zhang, Yan-yun Wang, et al. Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model[J]. Chinese Journal of Integrative Medicine, 2014,20(4):280-285.
Huang, Sj., Zhang, Xh., Wang, Yy. et al. Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model., Chin. J. Integr. Med. 20, 280–285 (2014). https://doi.org/10.1007/s11655-014-1343-0 DOI：

Shi-jing Huang, Xian-hui Zhang, Yan-yun Wang, et al. Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model[J]. Chinese Journal of Integrative Medicine, 2014,20(4):280-285. DOI： 10.1007/s11655-014-1343-0.

摘要

To determine the mechanisms underlying the anti-depressant effects of Kaixin Jieyu Decoction (开心解郁汤

KJD) by investigating the effects of KJD on behavior

monoamine neurotransmitter levels

and serotonin (5-HT) receptor subtype expression in the brain in a rat model of depression. The rat depression model was established using chronic unpredictable mild stress (CUMS). Forty-eight Sprague Dawley rats were randomly divided into control

depression model (CUMS)

CUMS+KJD (7.7 g/kg−1·d−1 of crude drug)

and CUMS+fluoxetine (2.4 mg/kg−1·d−1) groups (n=12 in each group)

and the treatments lasted for 21 days. We regularly evaluated body weight

sucrose consumption

and horizontal and vertical activity scores in open-field tests. The content of the monoamine neurotransmitters 5-HT

norepinephrine (NE)

and dopamine (DA) and the DA metabolite homovanillic acid in the cerebral cortex

and 5-HT1A and 5-HT2A receptor mRNA in the cerebral cortex and the hippocampus

were determined respectively by high-performance liquid chromatography-coularray electrochemical detector and real-time polymerase chain reaction. Compared with the control group

CUMS rats showed a variety of depression-like behavioral changes

including a significant reduction in body weight

sucrose consumption

and horizontal and vertical activity scores in open-field tests (P<0.05 or P<0.01)

and a significant decrease in 5-HT and NE levels and 5-HT2A receptor mRNA expression. In contrast

they showed a significant increase in 5-HT1A receptor mRNA expression in the cerebral cortex. In the hippocampus

5-HT1A receptor mRNA expression was lower whereas 5-HT2A receptor mRNA expression was higher than in the control group (P<0.05 or P<0.01). Treatment with KJD or fluoxetine partially attenuated these changes (P<0.05 or P<0.01). KJD could normalize the levels of 5-HT and NE and adjust the balance of 5-HT1A and 5-HT2A receptor expression in rat cerebrum

and this may be one of mechanisms of antidepressant effects of KJD.

Abstract

To determine the mechanisms underlying the anti-depressant effects of Kaixin Jieyu Decoction (开心解郁汤

KJD) by investigating the effects of KJD on behavior

monoamine neurotransmitter levels

depression model (CUMS)

CUMS+KJD (7.7 g/kg−1·d−1 of crude drug)

and CUMS+fluoxetine (2.4 mg/kg−1·d−1) groups (n=12 in each group)

and the treatments lasted for 21 days. We regularly evaluated body weight

sucrose consumption

and horizontal and vertical activity scores in open-field tests. The content of the monoamine neurotransmitters 5-HT

norepinephrine (NE)

and dopamine (DA) and the DA metabolite homovanillic acid in the cerebral cortex

and 5-HT1A and 5-HT2A receptor mRNA in the cerebral cortex and the hippocampus

were determined respectively by high-performance liquid chromatography-coularray electrochemical detector and real-time polymerase chain reaction. Compared with the control group

CUMS rats showed a variety of depression-like behavioral changes

including a significant reduction in body weight

sucrose consumption

and horizontal and vertical activity scores in open-field tests (P<0.05 or P<0.01)

and a significant decrease in 5-HT and NE levels and 5-HT2A receptor mRNA expression. In contrast

they showed a significant increase in 5-HT1A receptor mRNA expression in the cerebral cortex. In the hippocampus

and this may be one of mechanisms of antidepressant effects of KJD.

关键词

depressionKaixin Jieyu Decoctionbehaviormonoamines neurotransmitterserotonin1A and serotonin2A receptor mRNA

Keywords

depressionKaixin Jieyu Decoctionbehaviormonoamines neurotransmitterserotonin1A and serotonin2A receptor mRNA

references

Berton O, Nestle EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006;7:137–151.

Huang SJ, Wu W, Fang SF. Discussion on vital qi-tonifying and stasis-eliminating therapy on vascular depression. Chin J Inf Traidit Chin Med (Chin) 2009;16:85–86.

Lin YH, Liu AH, Xu Y, Tie L, Yu HM, Li XJ. Effect of chronic unpredictable mild stress on brain-pancreas: relative protein in rat brain and pancreas. Behav Brain Res 2005;165:63–71.

Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997;134:319–329.

Wang SS, Yan XB, Hofman MA, Swaab DF, Zhou JN. Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress. Neurosci Bull 2010;26:297–303.

van Praag HM. Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 2004;28:891–907.

Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. J Neuropsychobiol 2005;52:90–110.

Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008;358:55–68.

Páez-Pereda M. New drug targets in the signaling pathways activated by antidepressants. Pro Neuropsychopharmacol Biol Psychiatry 2005;29:1010–1016.

Green AR. Neuropharmacology of 5-hydroxytryptamine. Br J Pharmacol 2006;147:S145–S152.

Filip M, Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep 2009;61:761–777.

Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP, et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci 2006;26:5554.

Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805–809.

Carli M, Baviera M, Invernizzi RW, Balducci C. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 2006;31:757–767.

Blier P, Ward N M. Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 2003;53:193–203.

Katz MM, Tekell JL, Bowden CL, Brannan S, Houston JP, Berman N, et al. Onset and early behavioral effects of pharmacologically different anti-depressants and placebo in depression. Neuropsychopharmacology 2004;29:566–579.

Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234–241.

Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008;33:2080–2092.

Marek GJ, Martin-Ruiz R, Abo A, Artigas F. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 2005;30:2205–2215.

Szabo ST, Blier P. Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT2A receptor antagonism on the firing activity of norepinephrine neurons. J Pharmacol Exp Ther 2002;302:983–991.

FULL TEXT LINK

More>

浏览量

1008

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model

Pinching spine: A potential treatment for depression

Multiple pharmacological actions of Yiqi Huatan Decoction (益气化痰方) in a model of depression in rats

Effects of electro-acupuncture on personality traits in depression: A randomized controlled study

The relevance between symptoms and magnetic resonance imaging analysis of the hippocampus of depressed patients given electro-acupuncture combined with Fluoxetine intervention — A randomized, controlled trial